Ruben Amaro, Charlie Manuel

As Phillies reach .500, GM Ruben Amaro looking to address center field and bullpen

27 Comments

Though the Phillies, at long last, reached .500 for the first time since June 7, one would think most signs point to the team being sellers at the deadline. Yesterday, they lost center fielder Ben Revere to a broken foot and he will be sidelined for six to eight weeks. They have a few soon-to-be free agents. The Minor League system is still a little light on legitimate talent. They also rank among the bottom-ten in baseball in run differential at -45.

On the subject of improving the roster, GM Ruben Amaro asked rhetorically, “How do I do it? I don’t know. We’ll find out. I’m the GM. I’m supposed to be able to do this stuff I guess.”

Amaro told the media prior to this afternoon’s first-half finale that he is looking for upgrades in center field and in the bullpen. He said, “we’ll probably be looking for a centerfielder if there’s one that’s available. I don’t know if there’s one available or one that will be an upgrade from what we have right now with John [Mayberry] being out there.”

As it turned out, Mayberry helped the Phillies walk off in today’s first-half finale against the White Sox with an RBI single up the middle in the tenth inning. It was the third extra inning game the two teams had played in a 36-hour period. (Per Jayson Stark, it’s the first time all three games of a series went extras since the Athletics and White Sox did it May 11-13, 2011.) The Phillies emerged victorious in two of them and finish the ten-game homestand — which Amaro explicitly was using as a barometer for the team’s buyer or seller status — at 7-3. The Braves lost to the Reds, so the Phillies will enter the first half six games behind in third place.

Carlos Ruiz leaves a goodbye note for the Phillies

CLEARWATER, FL - FEBRUARY 26:  Carlos Ruiz #51 of the Philadelphia Phillies poses for a portrait on February 26, 2016 at Bright House Field in Clearwater, Florida.  (Photo by Elsa/Getty Images)
Leave a comment

And then there was one. One player from the 2008 World Series champs, that is. Ryan Howard likely isn’t going anywhere so he’ll be the last one to turn the lights off, but today Carlo Ruiz bid adieu to the Phillies following his trade to Los Angeles.

Lost in all of the emotions the Dodgers are reported to be feeling about A.J. Ellis leaving is the fact that Ruiz was one of the most beloved Phillies players ever, by both his teammates and their fans. Yesterday Roy Halladay penned a heartfelt goodbye to Ruiz, suggesting that he was every bit as essential to his and the Phillies’ success as Ellis has been to Clayton Kershaw (and in pure baseball production, obviously, quite more).

Today Chooch left a message for his now former teammates:

A far-fetched sounding drug test scam

NES TSIONA, ISRAEL - JANUARY 22:  A laboratory technician checks human blood samples before placing the glass tubes on an automated testing line at the Maccabi Health Services HMO central laboratory January 22, 2006 in Nes Tsiona which is located in central Israel. The laboratory, which operates a fully automated system complete with advanced robotics, can test more than 50,000 blood samples a day. The lab is considered one of the most modern of its kind in the western world.  (Photo by David Silverman/Getty Images)
Getty Images
9 Comments

Kevin Draper at Deadspin is passing along a story — and that’s not me editorializing; he’s admitting that it’s unconfirmed gossip at the moment — about a major league player paying a teammate $2.5 million to take the fall for him on a drug test. The story came via a tip from someone who, apparently, had a conversation about the drug test scam with a college baseball player who knew the players allegedly involved in the scam.

Here is how the conversation was recounted:

College Baseball Player: [MLB player’s star teammate] paid him to take his blood test. $2.5 million dollars.

Bar Patron: How does that even work?

College Baseball Player: [MLB player] and [MLB player’s star teammate] were getting tested the same day. They traded samples.

Deadspin says that the story is “probably bulls**t” but that some preliminary investigating they’ve done doesn’t disprove it and, to some extent corroborates it. How it’s been supported or not is left unclear and Deadspin couches all of this in a request for more information if anyone has any. Which, OK, fine.

I’ll offer that, on the surface, this seems like a bit more than mere “bulls**t.” It sounds structurally impossible. If it’s a blood test for HGH as the excerpt suggests, the samples are tested back in the lab to make sure they match up with previous samples. Meaning: the lab processing the sample knows if it’s your blood or not. If it’s a urine test, as Deadspin thinks it may have been, I’m not sure how samples could be switched given that urine tests are directly observed by testing officials. Yes, they watch you pee. They’d likely prevent you from peeing right next to your bro teammate, but even if you did, they’d see you exchange little plastic containers of urine with him.

I’m not going to say that this is 100% bull because we can’t really know for sure, but the scenario as described sounds highly unlikely, approaching the impossible. If someone had a story about bribing a sample taker with $2.5 million well, hey, maybe we’re getting somewhere, because that would get you over some procedural hurdles. For now, though, this all sounds like someone passing along a tall tale.

If it is true? Hoo boy, that’d be fun. At least for people like me who write about this stuff.